Vertex Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
VRTX Vertex Pharmaceuticals Inc
NAPA Duckhorn Portfolio Inc
NDACU Nightdragon Acquisition Corp
EMPYF Empress Royalty Corp
CGC Canopy Growth Corp
FMCB Farmers & Merchants Bancorp
GM General Motors Co
CBMB CBM Bancorp Inc
SCHW Charles Schwab Corp
WSC Willscot Mobile Mini Holdings Corp
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Vertex Pharmaceuticals Incorporated is a biotechnology company. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI and KALYDECO. It offers its products to treat people with CF who have specific mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene. Its CFTR correctors, such as lumacaftor, tezacaftor, and elexacaftor, help CFTR proteins reach the cell surface. It offers pipeline of small molecule medicines in other serious diseases where it has insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases.

Closing Price
$203.81
Day's Change
-0.64 (-0.31%)
Bid
--
Ask
--
B/A Size
--
Day's High
206.43
Day's Low
202.00
Volume
(Average)
Volume:
2,870,267

10-day average volume:
2,792,188
2,870,267
  • Prev Close
    204.45
  • Today's Open
    205.78
  • Day's Range
    202.00-206.43
  • Avg Vol (10-day)
    2.8M
  • Last (time)
    4:00p ET 12/03/21
  • Last (size)
    10
  • 52-Wk Range
    176.36 - 242.99
    LowHigh
  • (01/25/21 - 10/06/21)
    15.56%
  • 26.5%
  • Market Cap
    51.8B
  • Shares Outstanding
    254.3M
  • 8.34
  • 24.51x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 91.53
  • (% of float 11/15/21)
    1.14

Latest News

December 03, 2021
5:29 pm ET
MarketWatch
December 02, 2021
5:29 pm ET
MarketWatch
December 01, 2021
5:29 pm ET
MarketWatch
7:30 am ET
BusinessWire
November 30, 2021
5:28 pm ET
MarketWatch
November 29, 2021
5:29 pm ET
MarketWatch
November 24, 2021
5:29 pm ET
MarketWatch
November 23, 2021
5:29 pm ET
MarketWatch
November 22, 2021
5:28 pm ET
MarketWatch
November 19, 2021
5:28 pm ET
MarketWatch
8:52 am ET
MarketWatch
6:00 am ET
BusinessWire
November 18, 2021
5:28 pm ET
MarketWatch
November 17, 2021
5:28 pm ET
MarketWatch
November 16, 2021
5:28 pm ET
MarketWatch
November 15, 2021
5:28 pm ET
MarketWatch
November 12, 2021
5:28 pm ET
MarketWatch
7:27 am ET
BusinessWire
November 11, 2021
5:28 pm ET
MarketWatch
November 10, 2021
5:29 pm ET
MarketWatch
November 09, 2021
5:29 pm ET
MarketWatch
November 08, 2021
5:28 pm ET
MarketWatch
November 05, 2021
5:29 pm ET
MarketWatch
November 04, 2021
5:35 pm ET
MarketWatch
November 03, 2021
5:29 pm ET
MarketWatch
November 02, 2021
5:29 pm ET
MarketWatch
4:01 pm ET
BusinessWire
November 01, 2021
5:29 pm ET
MarketWatch
October 29, 2021
5:29 pm ET
MarketWatch
October 28, 2021
5:29 pm ET
MarketWatch
October 27, 2021
5:29 pm ET
MarketWatch
October 26, 2021
5:29 pm ET
MarketWatch
9:00 am ET
BusinessWire
October 25, 2021
5:29 pm ET
MarketWatch
October 22, 2021
5:29 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.